Personal Information
Organización/Lugar de trabajo
Cincinnati Area, Ohio United States
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
www.compliance-insight.com
Acerca de
I’m the “architect” with GMP Oversight – I coach and instruct the client’s Quality Management to see the processes, understand what needs to be controlled and where to control it.
My directive for our specialists is that they approach all projects with real-world, hands-on experience. With an eye always on the goal rather than focusing on the pathway, they are to use enterprising and creative ways to achieve effective and practical compliance solutions.
Etiquetas
fda
compliance insight
warning letter
483
fda 483 warning letter
fda warning letter
fda 483
fda inspection
fda audit
fda 483 inspection
gcp
good clinical practices
clinical
fda warnin letter
quailty manger
fda consulting
fda consent decree
fda gmp
fda gmp trining
gmp
fda documentation
211.192
fda compliance
21cfr 201 211
Ver más
Presentaciones
(16)Documentos
(1)Recomendaciones
(3)FDA audit series part 5, dealing with the 483 or Warning Letter
Compliance Insight, Inc.
•
Hace 10 años
Fda Inspection
Compliance Insight, Inc.
•
Hace 10 años
Pharma Uptoday : Volume 2 issue may 2014
Sathish Vemula
•
Hace 10 años
Personal Information
Organización/Lugar de trabajo
Cincinnati Area, Ohio United States
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
www.compliance-insight.com
Acerca de
I’m the “architect” with GMP Oversight – I coach and instruct the client’s Quality Management to see the processes, understand what needs to be controlled and where to control it.
My directive for our specialists is that they approach all projects with real-world, hands-on experience. With an eye always on the goal rather than focusing on the pathway, they are to use enterprising and creative ways to achieve effective and practical compliance solutions.
Etiquetas
fda
compliance insight
warning letter
483
fda 483 warning letter
fda warning letter
fda 483
fda inspection
fda audit
fda 483 inspection
gcp
good clinical practices
clinical
fda warnin letter
quailty manger
fda consulting
fda consent decree
fda gmp
fda gmp trining
gmp
fda documentation
211.192
fda compliance
21cfr 201 211
Ver más